PubMed record
A supplement cannot replace the liver
[6] GLP-1 receptor agonists : Including semaglutide (Wegovy) and liraglutide (Saxenda), both MHRA-licensed for weight management with extensive clinical trial evidence demonstrating significant weight loss
Moreover, GLP-1 and its analogs have shown positive effects in kidney protection, neuroprotection, and lipid metabolism regulation, and they hold promise in treating conditions like non-alcoholic steatohepatitis (NASH) and Alzheimer's disease
GHK-Cu: 7 Proven Facts About the Buzzy Peptide Youre three videos deep into your For You page when someone holds up a tiny blue bottle and swears GHK-Cu is the reason her skin looks like that
The second group included individuals who started and continued either a GLP-1 receptor agonist or SGLT-2 inhibitor for the first time between January 1, 2013, and December 31, 2020